Total Payments
$206,910
2024 Payments
$185,600
Companies
37
Transactions
750
Medicare Patients
2,452
Medicare Billing
$309,874
Payment Breakdown by Category
Other$161,247 (77.9%)
Food & Beverage$25,245 (12.2%)
Consulting$13,616 (6.6%)
Travel$6,366 (3.1%)
Education$435.07 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $158,747 | 74 | 76.7% |
| Food and Beverage | $25,245 | 642 | 12.2% |
| Consulting Fee | $13,616 | 6 | 6.6% |
| Travel and Lodging | $6,366 | 18 | 3.1% |
| Honoraria | $2,500 | 1 | 1.2% |
| Education | $435.07 | 9 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $155,188 | 234 | $0 (2024) |
| GlaxoSmithKline, LLC. | $12,153 | 83 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $6,755 | 13 | $0 (2024) |
| Hikma Pharmaceuticals USA | $6,237 | 7 | $0 (2024) |
| CSL Behring | $6,193 | 49 | $0 (2024) |
| GENZYME CORPORATION | $3,951 | 42 | $0 (2024) |
| ADMA BioManufacturing LLC | $3,540 | 5 | $0 (2024) |
| Pharming Healthcare, Inc. | $2,939 | 7 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $2,593 | 66 | $0 (2024) |
| Amgen Inc. | $1,927 | 71 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $185,600 | 315 | AstraZeneca Pharmaceuticals LP ($149,117) |
| 2023 | $9,519 | 172 | AstraZeneca Pharmaceuticals LP ($2,842) |
| 2022 | $4,454 | 143 | AstraZeneca Pharmaceuticals LP ($1,177) |
| 2021 | $2,600 | 45 | AstraZeneca Pharmaceuticals LP ($1,100) |
| 2020 | $2,008 | 30 | AstraZeneca Pharmaceuticals LP ($549.02) |
| 2019 | $2,296 | 36 | AstraZeneca Pharmaceuticals LP ($402.70) |
| 2018 | $189.02 | 5 | Janssen Pharmaceuticals, Inc ($78.43) |
| 2017 | $244.67 | 4 | CSL Behring ($115.39) |
All Payment Transactions
750 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/28/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/23/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $34.50 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $150.00 | General |
| Category: Respiratory | ||||||
| 12/16/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: Immunology | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,112.00 | General |
| Category: Immunology | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: Immunology | ||||||
| 12/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: Immunology | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $8.47 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TAKHZYRO (Biological) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: GENETIC DISEASE | ||||||
| 12/03/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.06 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $6.28 | General |
| Category: IMMUNOLOGY | ||||||
| 11/28/2024 | CSL Behring | Haegarda (Biological) | Education | In-kind items and services | $60.73 | General |
| Category: Immunology | ||||||
| 11/28/2024 | CSL Behring | Haegarda (Biological) | Education | In-kind items and services | $60.73 | General |
| Category: Immunology | ||||||
| 11/28/2024 | CSL Behring | Haegarda (Biological) | Education | In-kind items and services | $60.73 | General |
| Category: Immunology | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $10.19 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/22/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: Immunology | ||||||
| 11/16/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $5,325.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,207 | 15,143 | $517,905 | $182,783 |
| 2022 | 13 | 950 | 10,003 | $333,278 | $118,610 |
| 2021 | 5 | 295 | 1,359 | $30,017 | $8,481 |
Total Patients
2,452
Total Services
26,505
Medicare Billing
$309,874
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2357 | Injection, omalizumab, 5 mg | Office | 2023 | 20 | 2,715 | $174,194 | $82,299 | 47.2% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 71 | 3,780 | $94,400 | $39,510 | 41.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 124 | 124 | $42,780 | $13,745 | 32.1% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 72 | 4,946 | $59,352 | $13,393 | 22.6% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 508 | 1,633 | $61,782 | $12,057 | 19.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 109 | $28,605 | $9,160 | 32.0% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 70 | 1,139 | $20,502 | $6,307 | 30.8% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 97 | 370 | $11,052 | $2,313 | 20.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 37 | 130 | $9,100 | $1,347 | 14.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 37 | 37 | $5,735 | $1,026 | 17.9% |
| 70486 | Ct scan of face without contrast | Office | 2023 | 16 | 16 | $7,472 | $985.80 | 13.2% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 19 | 20 | $1,838 | $385.80 | 21.0% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 19 | 19 | $988.00 | $250.99 | 25.4% |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 2023 | 34 | 105 | $105.00 | $2.79 | 2.7% |
| J2357 | Injection, omalizumab, 5 mg | Office | 2022 | 21 | 2,115 | $135,698 | $59,558 | 43.9% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 26 | 1,060 | $24,380 | $11,912 | 48.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 97 | 97 | $28,615 | $10,255 | 35.8% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 58 | 3,839 | $46,068 | $10,161 | 22.1% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 407 | 1,329 | $45,186 | $9,683 | 21.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 85 | $16,575 | $7,637 | 46.1% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2022 | 54 | 859 | $12,026 | $4,898 | 40.7% |
| 95115 | Professional service for single injection of allergen | Office | 2022 | 93 | 346 | $8,996 | $2,014 | 22.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 36 | 112 | $7,840 | $1,127 | 14.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 36 | 36 | $5,580 | $911.88 | 16.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 16 | 16 | $1,440 | $273.86 | 19.0% |
About Dr. Nicholas Kolinsky, DO
Dr. Nicholas Kolinsky, DO is a Allergy & Immunology healthcare provider based in Maryville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2016. The National Provider Identifier (NPI) number assigned to this provider is 1033569439.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicholas Kolinsky, DO has received a total of $206,910 in payments from pharmaceutical and medical device companies, with $185,600 received in 2024. These payments were reported across 750 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($158,747).
As a Medicare-enrolled provider, Kolinsky has provided services to 2,452 Medicare beneficiaries, totaling 26,505 services with total Medicare billing of $309,874. Data is available for 3 years (2021–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Other Specialties Internal Medicine
- Location Maryville, TN
- Active Since 06/16/2016
- Last Updated 01/08/2026
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1033569439
Products in Payments
- AIRSUPRA (Drug) $73,301
- TEZSPIRE (Biological) $59,631
- FASENRA (Biological) $21,990
- NUCALA (Biological) $11,582
- DUPIXENT (Biological) $6,402
- Ryaltris (Drug) $6,237
- JOENJA (Drug) $2,787
- Haegarda (Biological) $1,420
- Xolair (Biological) $716.28
- FASENRA (Drug) $699.07
- HYQVIA (Biological) $610.91
- Odactra (Drug) $375.29
- TRELEGY ELLIPTA (Drug) $354.42
- TAKHZYRO (Biological) $354.40
- XARELTO (Drug) $295.43
- BREZTRI (Drug) $282.21
- AYVAKIT (Drug) $258.06
- CUVITRU (Biological) $165.62
- Xembify (Biological) $159.33
- RUCONEST (Biological) $152.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.